In Vitro Diagnostics Market Size, Share, Growth & Industry Analysis, By Product Type (Instruments, Reagents & Kits, Software Control Products), By Technology (Immunoassays, Molecular Diagnostics, Clinical Chemistry & Others), By Application (Infectious Diseases, Others), By End-User and Regional Analysis, 2024-2031

TABLE OF CONTENT

1 INTRODUCTION OF THE GLOBAL IN VITRO DIAGNOSTICS MARKET 
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL IN VITRO DIAGNOSTICS MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL IN VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE
6.1 Overview
6.2 Instruments
6.2.1 Immunoassay Analyzers
6.2.2 Molecular Diagnostics Instruments
6.2.3 Centrifuges
6.3 Reagents & Kits
6.3.1 Immunoassay Kits
6.3.2 Molecular Diagnostic Kits
6.3.3 Others
6.4 Software
6.5 Control Products

7 GLOBAL IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY
7.1 Overview
7.2 Immunoassays
7.2.1 Enzyme-Linked Immunosorbent Assay (ELISA)
7.2.2 Lateral Flow Immunoassay
7.2.3 Others 
7.3 Molecular Diagnostics
7.3.1 Polymerase Chain Reaction (PCR)
7.3.2 Next-Generation Sequencing (NGS)
7.3.3 Microarrays
7.4 Clinical Chemistry
7.4.1 Spectrophotometry
7.4.2 Others 
7.5 Hematology
7.6 Microbiology

8 GLOBAL IN VITRO DIAGNOSTICS MARKET, BY APPLICATION
8.1 Overview
8.2 Infectious Diseases
8.3 Oncology
8.4 Cardiology
8.5 Diabetes
8.6 Others 

9 GLOBAL IN VITRO DIAGNOSTICS MARKET, BY END-USER
9.1 Overview
9.2 Hospitals
9.3 Diagnostic Laboratories
9.4 Home Care
9.5 Blood Banks 

10 GLOBAL IN VITRO DIAGNOSTICS MARKET, BY GEOGRAPHY
10.1 Overview

11 NORTH AMERICA 
11.1 U.S.
11.2 Canada
11.3 Mexico

12 EUROPE 
12.1 Germany
12.2 UK
12.3 France
12.4 Italy
12.5 Spain
12.6 Russia
12.7 Rest of Europe

13 ASIA-PACIFIC 
13.1 China
13.2 Japan
13.3 India
13.4 South Korea
13.5 Rest of Asia-Pacific

14 MIDDLE EAST & AFRICA 
14.1 GCC
14.2 South Africa
14.3 North Africa
14.4 Rest of Middle East & Africa

15 LATIN AMERICA 
15.1 Brazil
15.2 Argentina
15.3 Rest of South America

16 GLOBAL IN VITRO DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
16.1 Overview
16.2 Key Developments
16.3 Key Strategic Developments
16.4 Company Market Ranking
16.5 Regional Footprint
16.6 Industry Footprint

17 COMPANY PROFILES
17.1 F. Hoffmann-La Roche Ltd
17.1.1 Key Facts
17.1.2 Financial Overview
17.1.3 Product Benchmarking
17.1.4 Recent Developments
17.1.5 Winning Imperatives
17.1.6 Current Focus & Strategies
17.1.7 Threat from competition
17.1.8 SWOT Analysis
17.2 Siemens Healthcare Private Limited
17.2.1 Key Facts
17.2.2 Financial Overview
17.2.3 Product Benchmarking
17.2.4 Recent Developments
17.2.5 Winning Imperatives
17.2.6 Current Focus & Strategies
17.2.7 Threat from competition
17.2.8 SWOT Analysis
17.3 Abbott
17.3.1 Key Facts
17.3.2 Financial Overview
17.3.3 Product Benchmarking
17.3.4 Recent Developments
17.3.5 Winning Imperatives
17.3.6 Current Focus & Strategies
17.3.7 Threat from competition
17.3.8 SWOT Analysis
17.4 Danaher Corporation
17.4.1 Key Facts
17.4.2 Financial Overview
17.4.3 Product Benchmarking
17.4.4 Recent Developments
17.4.5 Winning Imperatives
17.4.6 Current Focus & Strategies
17.4.7 Threat from competition
17.4.8 SWOT Analysis
17.5 Thermo Fisher Scientific Inc
17.5.1 Key Facts
17.5.2 Financial Overview
17.5.3 Product Benchmarking
17.5.4 Recent Developments
17.5.5 Winning Imperatives
17.5.6 Current Focus & Strategies
17.5.7 Threat from competition
17.5.8 SWOT Analysis
17.6 Becton, Dickinson and Company
17.6.1 Key Facts
17.6.2 Financial Overview
17.6.3 Product Benchmarking
17.6.4 Recent Developments
17.7 Bio-Rad Laboratories, Inc
17.7.1 Key Facts
17.7.2 Financial Overview
17.7.3 Product Benchmarking
17.7.4 Recent Developments
17.8 SYSMEX CORPORATION
17.8.1 Key Facts
17.8.2 Financial Overview
17.8.3 Product Benchmarking
17.8.4 Recent Developments
17.9 QuidelOrtho Corporation
17.9.1 Key Facts
17.9.2 Financial Overview
17.9.3 Product Benchmarking
17.9.4 Recent Developments
17.10 BIOMÉRIEUX
17.10.1 Key Facts
17.10.2 Financial Overview
17.10.3 Product Benchmarking
17.10.4 Recent Developments

LIST OF TABLES

TABLE 1 Global In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 2 Global In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 3 Global In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 4 Global In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 5 Global In Vitro Diagnostics Market Revenue, By Geography, 2021 – 2031 (USD Million)
TABLE 6 North America In Vitro Diagnostics Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 7 North America In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 8 North America In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 9 North America In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 10 North America In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 11 US In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 12 US In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 13 US In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 14 US In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 15 Canada In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 16 Canada In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 17 Canada In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 18 Canada In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 19 Mexico In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 20 Mexico In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 21 Mexico In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 22 Mexico In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 23 Europe In Vitro Diagnostics Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 24 Europe In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 25 Europe In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 26 Europe In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 27 Europe In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 28 Germany In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 29 Germany In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 30 Germany In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 31 Germany In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 32 France In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 33 France In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 34 France In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 35 France In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 36 U.K. In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 37 U.K. In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 38 U.K. In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 39 U.K. In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 40 Spain In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 41 Spain In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 42 Spain In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 43 Spain In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 44 Italy In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 45 Italy In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 46 Italy In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 47 Italy In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 48 Russia In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 49 Russia In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 50 Russia In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 51 Russia In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 52 Rest of Europe In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 53 Rest of Europe In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 54 Rest of Europe In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 55 Rest of Europe In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 56 Asia-Pacific In Vitro Diagnostics Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 57 Asia-Pacific In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 58 Asia-Pacific In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 59 Asia-Pacific In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 60 Asia-Pacific In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 61 China In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 62 China In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 63 China In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 64 China In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 65 Japan In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 66 Japan In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 67 Japan In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 68 Japan In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 69 India In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 70 India In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 71 India In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 72 India In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 73 South Korea In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 74 South Korea In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 75 South Korea In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 76 South Korea In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 77 Rest of Asia-Pacific In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 78 Rest of Asia-Pacific In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 79 Rest of Asia-Pacific In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 80 Rest of Asia-Pacific In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 81 Middle East and Africa In Vitro Diagnostics Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 82 Middle East and Africa In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 83 Middle East and Africa In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 84 Middle East and Africa In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 85 Middle East and Africa In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 86 GCC In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 87 GCC In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 88 GCC In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 89 GCC In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 90 North Africa In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 91 North Africa In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 92 North Africa In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 93 North Africa In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 94 South Africa In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 95 South Africa In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 96 South Africa In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 97 South Africa In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 98 Rest of Middle East & Africa In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 99 Rest of Middle East & Africa In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 100 Rest of Middle East & Africa In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 101 Rest of Middle East & Africa In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 102 Latin America In Vitro Diagnostics Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 103 Latin America In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 104 Latin America In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 105 Latin America In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 106 Latin America In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 107 Brazil In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 108 Brazil In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 109 Brazil In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 110 Brazil In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 111 Argentina In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 112 Argentina In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 113 Argentina In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 114 Argentina In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 115 Rest of Latin America In Vitro Diagnostics Market Revenue, By Product Type, 2021 – 2031 (USD Million)
TABLE 116 Rest of Latin America In Vitro Diagnostics Market Revenue, By Technology, 2021 – 2031 (USD Million)
TABLE 117 Rest of Latin America In Vitro Diagnostics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 118 Rest of Latin America In Vitro Diagnostics Market Revenue, By End-User, 2021 – 2031 (USD Million)
TABLE 119 Company Market Ranking
TABLE 120 Regional Footprint
TABLE 121 Product Benchmarking
TABLE 122 Recent Developments
TABLE 123 Winning Imperatives

LIST OF FIGURES

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global In Vitro Diagnostics Market 2021-2031 (USD Million)
FIG. 4 Global In Vitro Diagnostics Market Geographical Analysis (CAGR %)
FIG. 5 Global In Vitro Diagnostics Absolute Market Opportunity (USD Million)
FIG. 6 Global In Vitro Diagnostics Market Attractiveness (USD Million)
FIG. 7 Global In Vitro Diagnostics Market, By Product Type, 2021-2031 (USD Million)
FIG. 8 Global In Vitro Diagnostics Market, By Technology, 2021-2031 (USD Million)
FIG. 9 Global In Vitro Diagnostics Market, By Application, 2021-2031 (USD Million)
FIG. 10 Global In Vitro Diagnostics Market, By End-User, 2021-2031 (USD Million)
FIG. 11 Research Methodology
FIG. 12 Research Process
FIG. 13 Bottom-Up Approach
FIG. 14 Top-Bottom Approach
FIG. 15 Market Dynamics Overview
FIG. 16 Porter's Five Forces Analysis
FIG. 17 Value Chain Analysis
FIG. 18 Macroeconomic Analysis
FIG. 19 Global In Vitro Diagnostics Market Revenue Share, By Product Type, 2023 and 2031 (%)
FIG. 20 Global In Vitro Diagnostics Market Revenue Share, By Technology, 2023 and 2031 (%)
FIG. 21 Global In Vitro Diagnostics Market Revenue Share, By Application, 2023 and 2031 (%)
FIG. 22 Global In Vitro Diagnostics Market Revenue Share, By End-User, 2023 and 2031 (%)
FIG. 23 Global In Vitro Diagnostics Market Revenue Share, By Geographic Regions, 2023 and 2031 (%)
FIG. 24 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 25 North America In Vitro Diagnostics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 26 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 27 Europe In Vitro Diagnostics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 28 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 29 Asia-Pacific In Vitro Diagnostics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 30 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 31 Middle East & Africa In Vitro Diagnostics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 32 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 33 Latin America In Vitro Diagnostics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 34 Key Strategic Development
FIG. 35 Key Facts
FIG. 36 Financial Overview
FIG. 37 SWOT Analysis